Brown Jade 4
4 · CELL THERAPEUTICS INC · Filed Jun 22, 2006
Insider Transaction Report
Form 4
Brown Jade
EVP, Chief Business Officer
Transactions
- Sale
Common Stock
2006-06-21$1.43/sh−2,400$3,432→ 85,696 total - Sale
Common Stock
2006-06-21$1.46/sh−3,400$4,964→ 80,996 total - Sale
Common Stock
2006-06-21$1.44/sh−1,300$1,872→ 84,396 total - Sale
Common Stock
2006-06-21$1.47/sh−1,600$2,352→ 79,396 total - Sale
Common Stock
2006-06-21$1.42/sh−1,900$2,698→ 88,096 total - Sale
Common Stock
2006-06-21$1.49/sh−600$894→ 77,496 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. Proceeds from the sale were used to cover taxes related to the vesting of restricted stock on June 14, 2006.